Cholesterol and Lipid Rafts in the Biogenesis of Amyloid-β Protein and Alzheimer's Disease

被引:6
|
作者
Pantelopulos, George A. [1 ]
Abraham, Conor B. [1 ]
Straub, John E. [1 ]
机构
[1] Boston Univ, Dept Chem, Boston, MA 02215 USA
基金
美国国家卫生研究院; 美国国家科学基金会;
关键词
amyloid precursor protein; cholesterol; cellular compartment; lipid bilayer; lipid phase; molecular dynamics; CLEAVING ENZYME 1; PRECURSOR-PROTEIN; GAMMA-SECRETASE; TRANSMEMBRANE DOMAIN; PLASMA-MEMBRANE; PHASE-BEHAVIOR; S-PALMITOYLATION; DISINTEGRIN/METALLOPROTEINASE ADAM10; CRITICAL FLUCTUATIONS; MAGNETIC-RESONANCE;
D O I
10.1146/annurev-biophys-062823-023436
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
Cholesterol has been conjectured to be a modulator of the amyloid cascade, the mechanism that produces the amyloid-beta (A beta) peptides implicated in the onset of Alzheimer's disease.We propose that cholesterol impacts the genesis of A beta not through direct interaction with proteins in the bilayer, but indirectly by inducing the liquid-ordered phase and accompanying liquid-liquid phase separations, which partition proteins in the amyloid cascade to different lipid domains and ultimately to different endocytotic pathways.We explore the full process of A beta genesis in the context of liquid-ordered phases induced by cholesterol, including protein partitioning into lipid domains, mechanisms of endocytosis experienced by lipid domains and secretases, and pH-controlled activation of amyloid precursor protein secretases in specific endocytotic environments. Outstanding questions on the essential role of cholesterol in the amyloid cascade are identified for future studies.
引用
收藏
页码:455 / 486
页数:32
相关论文
共 50 条
  • [31] Cholesterol, lipid rafts, and disease
    Simons, K
    Ehehalt, R
    JOURNAL OF CLINICAL INVESTIGATION, 2002, 110 (05): : 597 - 603
  • [32] Metabolism of amyloid-β peptide and Alzheimer's disease
    Iwata, N
    Saido, TC
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2006, 100 : 51P - 51P
  • [33] Inhibition of Amyloid-β Aggregation in Alzheimer's Disease
    Wang, Qiuming
    Yu, Xiang
    Li, Lingyan
    Zheng, Jie
    CURRENT PHARMACEUTICAL DESIGN, 2014, 20 (08) : 1223 - 1243
  • [34] Metabolism of amyloid-β peptide and Alzheimer's disease
    Iwata, N
    Higuchi, M
    Saido, TC
    PHARMACOLOGY & THERAPEUTICS, 2005, 108 (02) : 129 - 148
  • [35] Alzheimer's disease: the ins and outs of amyloid-β
    Beyreuther, Konrad
    Masters, Colin L.
    Nature, 1997, 389 (6652):
  • [36] Aluminum and Amyloid-β in Familial Alzheimer's Disease
    Mold, Matthew
    Linhart, Caroline
    Gomez-Ramirez, Johana
    Villegas-Lanau, Andres
    Exley, Christopher
    JOURNAL OF ALZHEIMERS DISEASE, 2020, 73 (04) : 1627 - 1635
  • [37] Amyloid-β: A double agent in Alzheimer's disease?
    Yu, Hao
    Wu, Jie
    BIOMEDICINE & PHARMACOTHERAPY, 2021, 139
  • [38] Citrullination of Amyloid-β Peptides in Alzheimer's Disease
    Mukherjee, Soumya
    Perez, Keyla A.
    Dubois, Celine
    Nisbet, Rebecca M.
    Li, Qiao-Xin
    Varghese, Shiji
    Jin, Liang
    Birchall, Ian
    Streltsov, Victor A.
    Vella, Laura J.
    McLean, Catriona
    Barham, Kevin J.
    Roberts, Blaine R.
    Masters, Colin L.
    ACS CHEMICAL NEUROSCIENCE, 2021, 12 (19): : 3719 - 3732
  • [39] Synaptic activity, amyloid-β and Alzheimer's disease
    Cirrito, John R.
    Holtzman, David M.
    ALZHEIMER: 100 YEARS AND BEYOND, 2006, : 209 - +
  • [40] Amyloid-β-directed immunotherapy for Alzheimer's disease
    Lannfelt, L.
    Relkin, N. R.
    Siemers, E. R.
    JOURNAL OF INTERNAL MEDICINE, 2014, 275 (03) : 284 - 295